Literature DB >> 11880258

cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia.

Carmela Marfella-Scivittaro1, Andrea Quiñones, Stephanie A Orellana.   

Abstract

Developmental control of cell proliferation is crucial, and abnormal principal cell proliferation may contribute to cystogenesis in polycystic kidney disease. This study investigates roles of cAMP and its primary effector, cAMP-dependent protein kinase (protein kinase A; PKA), in control of cell proliferation in filter-grown noncystic (NC) and cystic (CY)-derived principal cell cultures. These cultures had similar cAMP pathway characteristics upstream of PKA subunit distribution but differed in predicted PKA subtype distribution. Functionally, cultures were proliferative before polarization, with constitutively higher proliferation in CY cultures. NC cultures achieved levels similar to those of CY cultures on pharmacological manipulation of cAMP production or PKA activation or inhibition of PKA subtype I activity. Inhibition of overall PKA activity, or of PKA subtype II anchoring, diminished cAMP/PKA-mediated proliferation in NC cultures but had no effect on CY cultures. Polarized CY monolayers remained proliferative, but NC monolayers lost responsiveness. No large proliferation changes resulted from treatments of polarized cultures; however, polarized NC and CY cultures differed in poststimulation handling of PKA catalytic and type IIalpha regulatory subunits. Our results support PKA subtype regulation of prepolarization proliferation in NC principal cells and altered regulation of PKA in CY cells and suggest that differences at or downstream of PKA can contribute to altered proliferation in a developmental renal disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880258     DOI: 10.1152/ajpcell.00122.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth.

Authors:  D L Vogt; C D Gray; W S Young; S A Orellana; A T Malouf
Journal:  Mol Cell Neurosci       Date:  2007-07-24       Impact factor: 4.314

2.  Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells.

Authors:  Ni Qiu; Honghao Zhou; Zhousheng Xiao
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

3.  Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathway.

Authors:  Lin Sun; Vinay K Kondeti; Ping Xie; Kirtee Raparia; Yashpal S Kanwar
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

4.  Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.

Authors:  Yasunori Sato; Kenichi Harada; Shinichi Furubo; Kazuo Kizawa; Takahiro Sanzen; Mitsue Yasoshima; Satoru Ozaki; Kumiko Isse; Motoko Sasaki; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Cyclic nucleotide signaling in polycystic kidney disease.

Authors:  Xiaofang Wang; Christopher J Ward; Peter C Harris; Vicente E Torres
Journal:  Kidney Int       Date:  2009-11-18       Impact factor: 10.612

6.  The absence of prostaglandin e1 returned confluent cultures of highly proliferative murine polycystic kidney principal cells to a normal proliferation level.

Authors:  Stephanie A Orellana; Andrea M Quinones
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

7.  Cyclic phosphatidic acid stimulates cAMP production and inhibits growth in human colon cancer cells.

Authors:  Tamotsu Tsukahara; Yoshikazu Matsuda; Hisao Haniu
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.